Novonix (NVX) Common Equity (2020 - 2025)

Novonix (NVX) has reported Common Equity for 6 consecutive years, with $161.7 million the latest figure, recorded in Q4 2025.

• Quarterly Common Equity rose 17.5% year-over-year to $161.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $161.7 million (up 17.5% YoY) and the FY2025 annual result came in at $161.7 million, up 17.5% from the prior year.
• Common Equity rose to $161.7 million in Q4 2025 per NVX's latest filing, from $144.1 million in the prior quarter.
• Over the last five years, Common Equity for NVX reached as high as $264.2 million in Q4 2021 and fell as low as $130.2 million in Q2 2021.
• A 5-year average of $186.5 million and a median of $172.8 million in 2023 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2021 — Common Equity jumped 192.46% — and 2024, when it slipped 25.2%.
• Year by year, Common Equity stood at $264.2 million in 2021, then slipped by 14.43% to $226.1 million in 2022, then slipped by 18.63% to $183.9 million in 2023, then decreased by 25.2% to $137.6 million in 2024, then increased by 17.5% to $161.7 million in 2025.
• According to Business Quant data, Common Equity over the past three periods registered $161.7 million, $144.1 million, and $137.6 million for Q4 2025, Q2 2025, and Q4 2024 respectively.